151 related articles for article (PubMed ID: 2467135)
1. Amlodipine: a double-blind evaluation of the dose-response relationship in mild to moderate hypertension.
Frick MH; McGibney D; Tyler HM
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S76-8. PubMed ID: 2467135
[TBL] [Abstract][Full Text] [Related]
2. A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. Amlodipine Study Group.
Lorimer AR; Smedsrud T; Walker P; Tyler HM
J Hum Hypertens; 1989 Jun; 3(3):191-6. PubMed ID: 2527993
[TBL] [Abstract][Full Text] [Related]
3. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
4. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
5. Amlodipine with enalapril therapy in moderate-severe essential hypertension.
Jensen H; Garsdal P; Davies J
J Hum Hypertens; 1990 Oct; 4(5):541-5. PubMed ID: 2149389
[TBL] [Abstract][Full Text] [Related]
6. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
7. Amlodipine and captopril in moderate-severe essential hypertension.
Maclean D; Mitchell ET; Wilcox RG; Walker P; Tyler HM
J Hum Hypertens; 1988 Aug; 2(2):127-32. PubMed ID: 2977406
[TBL] [Abstract][Full Text] [Related]
8. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
Leonetti G;
Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
[TBL] [Abstract][Full Text] [Related]
9. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
Pathak L; Hiremath ; Kerkar PG; Manade VG
J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of amlodipine, a new long-acting calcium antagonist, in mild and moderate hypertension.
Escudero J; Hernandez H
Int J Clin Pharmacol Res; 1991; 11(5):243-6. PubMed ID: 1839989
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of amlodipine in patients with mild-to-moderate hypertension.
Olvera R; Samaniego V; Moguel R; Meaney E
Int J Clin Pharmacol Res; 1991; 11(5):237-41. PubMed ID: 1839988
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness and tolerance of amlodipine in treatment of patients with mild to moderate hypertension. Results of a long-term study with a new calcium antagonist].
Habeler G; Lenzhofer R; Pall H; Tomaschek A; Ziebart-Schroth A; Zirm B; Ganzinger U
Wien Klin Wochenschr; 1992; 104(1):16-20. PubMed ID: 1532108
[TBL] [Abstract][Full Text] [Related]
14. Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension.
Park S; Chung N; Kwon J; Yoon JH; Kim YJ; Han DS; Kim HS
Clin Ther; 2005 Apr; 27(4):441-50. PubMed ID: 15922817
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of amlodipine and the nifedipine retard preparation in the treatment of arterial hypertension].
Pivac N; Dobovisek J; Bagatin J; Gros Furek V; Rumboldt Z; Janezić A; Kveder R; Sjerobabski V; Simunić M; Sardelić S
Lijec Vjesn; 1993; 115(11-12):356-9. PubMed ID: 8176999
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension.
Lorimer AR; Anderson JA; Laher MS; Davies J; Lazarus JH; Taylor SH; Sanghera S
J Hum Hypertens; 1994 Jan; 8(1):65-8. PubMed ID: 8151609
[TBL] [Abstract][Full Text] [Related]
17. Nilvadipine in hypertension--experience in ambulatory treatment.
Hoffmann A; Kraul H; Burkardt I
Int J Clin Pharmacol Ther; 1997 May; 35(5):195-203. PubMed ID: 9174874
[TBL] [Abstract][Full Text] [Related]
18. Amlodipine in mild and moderate hypertension: initial Indian experience.
Khokhani RC; Chopra P; Karnik ND; Bajan KD; Ailiani R; Waknis SS; Joseph TA; Chawla KP
J Assoc Physicians India; 1993 Oct; 41(10):662-3. PubMed ID: 8294330
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]